Jesi Ramone
Internal Medicine · Brooklyn, NYNPI 1407819907
Payments from drug & device makers
Across 1,002 payments — averaging $625.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$245K
- AbbVie$181K
- Gilead$147K
- Janssen Products, LP$29K
- Merck$21K
- Theratechnologies Inc.$2K
- plus $1K from 9 others
What the payments were for
- Consulting fees$42,4257%
- Speaking & faculty fees$463,32474%
- Travel & lodging$94,19115%
- Food & beverage$26,6854%
- Education$2010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 317 | $245,202 |
| AbbVie | 297 | $181,462 |
| Gilead | 263 | $146,833 |
| Janssen Products, LP | 28 | $29,221 |
| Merck | 46 | $21,261 |
| Theratechnologies Inc. | 9 | $1,638 |
| Johnson & Johnson | 31 | $952 |
| Medline Industries LP | 3 | $90 |
| EMD Serono, Inc. | 2 | $35 |
| Dynavax Technologies Corporation | 1 | $32 |
| Boehringer Ingelheim | 1 | $29 |
| GSK | 1 | $23 |
| Exact Sciences | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$626,825 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 197 | $819,267 |
| DovatoDolutegravir Sodium/Lamivudine | 164 | $510,373 |
| CabenuvaCabotegravir/Rilpivirine | 63 | $409,529 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 80 | $396,018 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 43 | $197,928 |
| JanuviaSitagliptin Phosphate | 103 | $122,582 |
| JulucaDolutegravir/Rilpivirine | 25 | $110,863 |
| JardianceEmpagliflozin | 67 | $86,329 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 14 | $68,077 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 18 | $64,059 |
| DescovyEmtricitabine/Tenofov Alafenam | 23 | $47,077 |
| TivicayDolutegravir Sodium | 16 | $34,687 |
| LinzessLinaclotide | 38 | $23,629 |
| OzempicSemaglutide | 16 | $14,488 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 34 | $11,261 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyDovato, Cabenuva, Triumeq, Juluca, Tivicay | $245,202 | $1,263,381311 claims |
| GileadBiktarvy, Genvoya, Descovy | $146,833 | $934,421234 claims |
| Janssen Products, LPSymtuza | $29,221 | $396,01880 claims |
| MerckJanuvia | $21,261 | $122,582103 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $29 | $92,07678 claims |
| AbbVieLinzess | $181,462 | $23,62938 claims |
| GSKIncruse Ellipta | $23 | $6,49319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Brooklyn
- Bruce BergerBrooklyn$3.4M
- Nelly CohenBrooklyn$2.8M
- Jorge SerjeBrooklyn$1.3M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.